Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>		A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1038/s41577-020-0328-z

http://scihub22266oqcxt.onion/10.1038/s41577-020-0328-z
suck pdf from google scholar
32358580!7194244!32358580
unlimited free pdf from europmc32358580    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid32358580      Nat+Rev+Immunol 2020 ; 20 (6): 345-346
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • COVID-19: a case for inhibiting IL-17? #MMPMID32358580
  • Pacha O; Sallman MA; Evans SE
  • Nat Rev Immunol 2020[Jun]; 20 (6): 345-346 PMID32358580show ga
  • IL-17 and IL-17 receptor inhibitors boast an impressive safety history and are widely available. Here, we argue that targeting IL-17 is immunologically plausible as a strategy to prevent acute respiratory distress syndrome (ARDS) in coronavirus disease 2019 (COVID-19) and discuss why we think that a clinical trial of a drug in this class could be a logical addition to the effort to find effective therapies.
  • |COVID-19[MESH]
  • |Coronavirus Infections/complications/genetics/*immunology/therapy[MESH]
  • |Humans[MESH]
  • |Immunotherapy[MESH]
  • |Inflammation/etiology/therapy[MESH]
  • |Interleukin-17/*antagonists & inhibitors/genetics[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/complications/genetics/*immunology/therapy[MESH]


  • DeepDyve
  • Pubget Overpricing

    • suck abstract from ncbi

    Linkout box